Standard Dental Labs Signs $10 Million Equity Purchase Agreement with Twenty Four Capital

SDL can choose whether to draw on the facility, but any stock sales would dilute existing shareholders.

Rhea-AI Summary

Standard Dental Labs (TUTH) finalized an equity purchase agreement with Twenty Four Capital for potential common stock sales of up to $10 million. SDL controls when to request purchases and how much to seek within the agreement’s limits, and is not required to sell shares. Twenty Four Capital must purchase under a qualifying notice, subject to applicable conditions.

The $10 million is the maximum aggregate gross purchase price, not funding received at signing or guaranteed proceeds. Market-based pricing, share price and trading volume affect funding availability; any shares sold would dilute holders. SDL expects to use proceeds for laboratory investments, potential acquisitions, working capital and general corporate purposes.

3 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 4 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major pointUp to $10 million equity facility adds a financing option through Twenty Four Capital. 4.8× market cap
• Minor pointSDL controls purchase requests within agreement limits and has no obligation to sell shares.
• Minor point. Forward-looking: it has not happened yet and may not happen.Planned proceeds use includes laboratory investments and potential acquisitions.

Negative

• Major point. Forward-looking: it has not happened yet and may not happen.Common stock sales would dilute existing shareholders at prices determined by market-based formulas.
• Minor point$10 million maximum is neither funding received at signing nor guaranteed proceeds.
• Minor point. Forward-looking: it has not happened yet and may not happen.Funding per purchase depends partly on share price, trading volume and satisfaction of agreement conditions.
• Minor pointPotential acquisitions remain subject to due diligence, definitive agreements, financing and applicable closing conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Facility gives the Company discretion to access equity capital over time to support its Florida dental laboratory strategy

ORLANDO, Fla., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”), after several weeks of negotiation, today announced that it finalized its common stock purchase agreement with Twenty Four Capital LLC over the weekend. The agreement provides for the potential sale of up to $10 million of SDL common stock, subject to its terms and conditions.

The facility is designed to give SDL discretion over when to request purchases and how much capital to seek, within the agreement’s limits. Twenty Four Capital is obligated to purchase shares under a qualifying purchase notice, subject to the applicable conditions. SDL is not required to sell any shares. The $10 million figure represents the maximum aggregate gross purchase price contemplated by the agreement; it does not represent funding received at signing or a guarantee that SDL will receive the full amount.

Purchase prices are determined using market-based pricing formulas specified in the agreement. The amount SDL can obtain in any purchase will depend in part on the market price and trading volume of its shares, as well as satisfaction of the agreement’s other conditions. Any shares sold under the facility would dilute existing stockholders.

“Finalizing this agreement is an important step in expanding our financing options as we develop our Florida laboratory network,” said James D. Brooks, President and Chief Executive Officer of Standard Dental Labs Inc. “The facility allows us to decide when to seek funding in light of our operating needs and market conditions. We expect to evaluate its use alongside our other financing options as we pursue laboratory acquisitions and invest in our operations.”

SDL expects to use any proceeds it receives under the agreement for working capital, investments in its laboratory operations, potential acquisitions and general corporate purposes. The Company’s ability to complete acquisitions remains subject to due diligence, definitive agreements, financing and applicable closing conditions.

About Twenty Four Capital LLC

Twenty Four Capital LLC is a principal capital provider that develops structured equity and liquidity solutions for public companies and significant shareholders. Its offerings include structured equity facilities and customized financing solutions.

About Standard Dental Labs Inc.

Standard Dental Labs Inc. is a Florida-focused dental laboratory company pursuing growth through acquisitions and investment in domestic production capabilities. SDL serves dental practices through its laboratory operations and is focused on digital workflows, quality and responsive service. Its common stock trades on the OTCQB under the symbol TUTH.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the availability and potential use of the equity purchase facility, future financing, laboratory investments, acquisitions and growth plans. Words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “may” and similar expressions may identify these statements.

Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties. Actual results may differ materially. Among other factors, the Company may be unable to satisfy the conditions for purchases under the agreement; market price, trading volume and other contractual limits may restrict the amount or timing of funding; and the issuance of shares may dilute existing stockholders. Additional risks include financing availability, acquisition and integration risks, customer retention, operating performance and the risks described in the Company’s filings with the Securities and Exchange Commission and disclosures published through OTC Markets.

The $10 million maximum under the agreement should not be interpreted as cash currently available to the Company or as an assurance that the Company will receive that amount. Readers should not place undue reliance on forward-looking statements, which speak only as of the date made. Standard Dental Labs Inc. undertakes no obligation to update them except as required by law.

Investor & Media Contact

Standard Dental Labs Inc.
424 E Central Blvd, Suite 308, Orlando, FL 32801
Phone: (407) 789-1923
Email: info@sdl.care
Investors: https://sdl.care/investors

SOURCE: Standard Dental Labs Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Did Standard Dental Labs receive $10 million when it signed the Twenty Four Capital agreement?

No. The $10 million represents the maximum aggregate gross purchase price contemplated by the agreement, not funding received at signing. Receipt of the full amount is not guaranteed, and SDL is not required to sell any shares.

How are Standard Dental Labs shares priced under the Twenty Four Capital facility?

Purchase prices use market-based pricing formulas specified in the agreement. The amount SDL can obtain in any purchase depends partly on its share price and trading volume, as well as satisfaction of the agreement’s other conditions.